CA2461852A1 - Radially expandable endoprosthesis device with two-stage deployment - Google Patents
Radially expandable endoprosthesis device with two-stage deployment Download PDFInfo
- Publication number
- CA2461852A1 CA2461852A1 CA002461852A CA2461852A CA2461852A1 CA 2461852 A1 CA2461852 A1 CA 2461852A1 CA 002461852 A CA002461852 A CA 002461852A CA 2461852 A CA2461852 A CA 2461852A CA 2461852 A1 CA2461852 A1 CA 2461852A1
- Authority
- CA
- Canada
- Prior art keywords
- radially expandable
- expandable endoprosthesis
- endoprosthesis
- deploying
- annulus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
- A61F2250/0082—Additional features; Implant or prostheses properties not otherwise provided for specially designed for children, e.g. having means for adjusting to their growth
Abstract
A radially expandable endoprosthesis device with a valve prosthesis (40) having a two-stage deployment capability. The valve prosthesis (40) includes a ring construction or annulus (42) made of a superelastic alloy with a bioresorbable material coating (44) thereon. The superelastic alloy and bioresorbable material (44) can be used to adjust the size of the valve prosthesis (40) in response to the growth of a pediatric patient.
Description
2 PCT/US02/30828 RADIALLY EXPANDABLE ENDOPROSTHESIS DEVICE
WITH TWO-STAGE DEPLOYMENT
BACKGROUND OF THE INVENTION
1. Field of the Invention The present invention relates to a radially expandable endoprosthesis device with an at least two stage deployment capability and, more particularly, pertains to an annularly expandable heart valve prosthesis which is adapted for the long-term treatment of valvular diseases in infants, children and adolescents.
Basically, radially expandable endoprosthesis devices are employed in connection with the insertion and positioning of stents or stent-grafts into corporeal vessels, such as arteries or the like, and generally are constituted of stainless steel or nitinol (nickel-titanium alloy) or similar alloys. In the instance in which an endoprothesis employed as a stem, it is adapted to counteract acute vessel spasms which are frequently encountered in the emplacement of nitinol (nickel-titanium alloy) stents in arteries or body vessels.
In coronary arteries, any secondary enlargement of the stem would be adapted to serve for offsetting contractile forces which may result from intimal hyperplasia;
however, the prior art pursuant to the state of the technology, does not address itself to this aspect.
When employed in connection with abdominal aortic aneurysms (AAA), current stent-graft devices merely concern themselves with anchoring devices the stent-graft in its location of emplacement.
Heretofore, in the prior art, the problems encountered the use of such endoprosthesis devices have been addressed by various methods and physical and biological means.
Thus, in intimal hyperplasia of coronary arteries, additional angioplasty, or in the use of chemicals and pharmaceutical preparates, such as various drugs or radio-isotopes, these may be readily employed in order to attempt to reduce the hyperplasia.
Furthermore, the emplacement of external bands around abdominal aortic aneurysms (AAA) which are treated with stent-grafts has also been employed in order to account for any aneurysmal progression which may occur at a site which has been thought to be free of disease. When employed in pediatric heart valve disease cases, secondary surgeries are frequently needed in order to replace the smaller-sized valve prosthesis as the infant or child grows, as a result of an increase in the heart valve sizes requiring larger-sized prosthesis, this being at times the cause of severe discomfort, and even morbidity and increased morbidity rates for such tender patients.
2. Discussion of the Prior Art As disclosed in Duerig et al. U.S. Patent No. 6,179,878, a composite self expanding stent device incorporates a restraining element, in which a restraint sleeve is generally formed of a shape memory alloy, such as binary nickel titanium alloy, referred to generally as nitinol, and wherein restraint can be provided in the form of either sleeve, covering a mesh or perforated sheet. In that instance, the restraining element can be formed of a polymeric material which, in any event is not considered to be possessed of a property to enable the stmt device to undergo multiple dimensionally changing configurations at predetermined intervals in time so as provided a device with an at least two-stage deployment in a patient.
Lenker et al. U.S. Patent No. 6,176,875 discloses an endoluminal prosthesis and methods in the use thereof, which provides for limited radial expansion in controlled mode. However, the stent-graft construction illustrated and described therein is primarily equipped with a belt which may frangible or expansible in order to allow for further or subsequent expansion of the implanted or emplaced stem-graft device. This device also fails to provide for a combination of super-elastic shape memory alloys such as nitinol, and bioresorbable medical materials which enable the devices to undergo at least a two-stage or multiple deplacement stages at predetermined intervals in time.
Finally, Lock et al. U.S. Patent No. 5,383,926 discloses an expandable endoprosthesis device which is constituted of the combination of a memory alloy, possibly such as nitinol, with an expansion limiting structure which is selectively removable in order two subsequently allow for further radial expansion of the emplaced device, whereby the expansion limiting structure can be constituted of a dissolvable or severable band-like material. Although this endoprosthesis device may generally incorporate bioresorbable materials, the device described in this patent is not adapted for heart valve prostheses, particularly such as are intended for pediatric applications, which will enable the treatment of valvular diseases in children, whereby the annulus of the heart valve prosthesis can be caused over periods of time to expand as the child grows, thereby
WITH TWO-STAGE DEPLOYMENT
BACKGROUND OF THE INVENTION
1. Field of the Invention The present invention relates to a radially expandable endoprosthesis device with an at least two stage deployment capability and, more particularly, pertains to an annularly expandable heart valve prosthesis which is adapted for the long-term treatment of valvular diseases in infants, children and adolescents.
Basically, radially expandable endoprosthesis devices are employed in connection with the insertion and positioning of stents or stent-grafts into corporeal vessels, such as arteries or the like, and generally are constituted of stainless steel or nitinol (nickel-titanium alloy) or similar alloys. In the instance in which an endoprothesis employed as a stem, it is adapted to counteract acute vessel spasms which are frequently encountered in the emplacement of nitinol (nickel-titanium alloy) stents in arteries or body vessels.
In coronary arteries, any secondary enlargement of the stem would be adapted to serve for offsetting contractile forces which may result from intimal hyperplasia;
however, the prior art pursuant to the state of the technology, does not address itself to this aspect.
When employed in connection with abdominal aortic aneurysms (AAA), current stent-graft devices merely concern themselves with anchoring devices the stent-graft in its location of emplacement.
Heretofore, in the prior art, the problems encountered the use of such endoprosthesis devices have been addressed by various methods and physical and biological means.
Thus, in intimal hyperplasia of coronary arteries, additional angioplasty, or in the use of chemicals and pharmaceutical preparates, such as various drugs or radio-isotopes, these may be readily employed in order to attempt to reduce the hyperplasia.
Furthermore, the emplacement of external bands around abdominal aortic aneurysms (AAA) which are treated with stent-grafts has also been employed in order to account for any aneurysmal progression which may occur at a site which has been thought to be free of disease. When employed in pediatric heart valve disease cases, secondary surgeries are frequently needed in order to replace the smaller-sized valve prosthesis as the infant or child grows, as a result of an increase in the heart valve sizes requiring larger-sized prosthesis, this being at times the cause of severe discomfort, and even morbidity and increased morbidity rates for such tender patients.
2. Discussion of the Prior Art As disclosed in Duerig et al. U.S. Patent No. 6,179,878, a composite self expanding stent device incorporates a restraining element, in which a restraint sleeve is generally formed of a shape memory alloy, such as binary nickel titanium alloy, referred to generally as nitinol, and wherein restraint can be provided in the form of either sleeve, covering a mesh or perforated sheet. In that instance, the restraining element can be formed of a polymeric material which, in any event is not considered to be possessed of a property to enable the stmt device to undergo multiple dimensionally changing configurations at predetermined intervals in time so as provided a device with an at least two-stage deployment in a patient.
Lenker et al. U.S. Patent No. 6,176,875 discloses an endoluminal prosthesis and methods in the use thereof, which provides for limited radial expansion in controlled mode. However, the stent-graft construction illustrated and described therein is primarily equipped with a belt which may frangible or expansible in order to allow for further or subsequent expansion of the implanted or emplaced stem-graft device. This device also fails to provide for a combination of super-elastic shape memory alloys such as nitinol, and bioresorbable medical materials which enable the devices to undergo at least a two-stage or multiple deplacement stages at predetermined intervals in time.
Finally, Lock et al. U.S. Patent No. 5,383,926 discloses an expandable endoprosthesis device which is constituted of the combination of a memory alloy, possibly such as nitinol, with an expansion limiting structure which is selectively removable in order two subsequently allow for further radial expansion of the emplaced device, whereby the expansion limiting structure can be constituted of a dissolvable or severable band-like material. Although this endoprosthesis device may generally incorporate bioresorbable materials, the device described in this patent is not adapted for heart valve prostheses, particularly such as are intended for pediatric applications, which will enable the treatment of valvular diseases in children, whereby the annulus of the heart valve prosthesis can be caused over periods of time to expand as the child grows, thereby
3 obviating the need for further surgical procedures normally required in order to substitute larger-sized heart valve prosthesis structures or devices in the growing patients.
SUMMARY OF THE INVENTION
Accordingly, in order to provide an endoprosthesis device which is adapted to essentially provide for a mufti-stage deployment and which facilitates a radially and annular expansion which may be required during continual use thereof, the inventive device, such as a stent, stent-graft, or pursuant to a prefer ed embodiment, a heart valve prosthesis particularly for pediatric case is drawn to a novel combination of super-elastic or shape memory alloys and bioresorbable materials, which enables the devices to undergo multiple or at least two-stage configurations at predetermined time intervals depending upon the type of material employed in conformance with the needs of patients in which the devices are deployed. The bioresorbable materials may also serve as reservoirs for therapeutic agents, such as antibiotics, anticoagulants, and cytostatic drugs.
In one aspect, the device may comprise a coronary stmt which is capable of having at least one deployment stage, and that is constituted of a superelastic material with a bioresorbable coating or constraint structure operatively combined therewith.
This type of stent may be suitable for counteracting or addressing problems relative to initmal hyperplasmia when utilized in coronary vessels, and can also be employed for the
SUMMARY OF THE INVENTION
Accordingly, in order to provide an endoprosthesis device which is adapted to essentially provide for a mufti-stage deployment and which facilitates a radially and annular expansion which may be required during continual use thereof, the inventive device, such as a stent, stent-graft, or pursuant to a prefer ed embodiment, a heart valve prosthesis particularly for pediatric case is drawn to a novel combination of super-elastic or shape memory alloys and bioresorbable materials, which enables the devices to undergo multiple or at least two-stage configurations at predetermined time intervals depending upon the type of material employed in conformance with the needs of patients in which the devices are deployed. The bioresorbable materials may also serve as reservoirs for therapeutic agents, such as antibiotics, anticoagulants, and cytostatic drugs.
In one aspect, the device may comprise a coronary stmt which is capable of having at least one deployment stage, and that is constituted of a superelastic material with a bioresorbable coating or constraint structure operatively combined therewith.
This type of stent may be suitable for counteracting or addressing problems relative to initmal hyperplasmia when utilized in coronary vessels, and can also be employed for the
4 stenting of other body vessels subjected to abdominal aortic aneurysms (AAA) when there is encountered the need to maintain contact with a dynamic vessel wall of a body vessel or lumen. In those last-mentioned instances, a stent for the counteracting the effects~of the aneurysms, when constituted of the combination of superelastic alloys and bioresorabable materials can offset post-deployment aneurismal dilatation.
In a particularly preferred embodiment of the invention, the endoprosthesis device, which is constituted of a combination of a superelastic alloy and bioresorabable material, is in the configuration of a heart valve prosthesis especially adapted for pediatric medical uses, and which can be made to expand in at least two-steps of its deployment as the infant or child grows, over an extended period of time. In that connection, the endoprosthesis device may be constructed so as to incorporate various types of polymer systems in order to afford multiple stage deployments, wherein particular types of polymers may degrade at time intervals of, for example, ranging 1 S from about 6 months to about 200 months after the implanting of the device in the pediatric patient. In particular, such a system is useful in long-term heart valve prostheses, whereas contrastingly another system may utilize a polymer which absorbs in 15 minutes and which is useful in implanting anastomotic devices.
Accordingly, it is a primary object of the present invention to provide an endoprosthesis device which is constituted of a combination of superelastic alloys and bioresorbable
In a particularly preferred embodiment of the invention, the endoprosthesis device, which is constituted of a combination of a superelastic alloy and bioresorabable material, is in the configuration of a heart valve prosthesis especially adapted for pediatric medical uses, and which can be made to expand in at least two-steps of its deployment as the infant or child grows, over an extended period of time. In that connection, the endoprosthesis device may be constructed so as to incorporate various types of polymer systems in order to afford multiple stage deployments, wherein particular types of polymers may degrade at time intervals of, for example, ranging 1 S from about 6 months to about 200 months after the implanting of the device in the pediatric patient. In particular, such a system is useful in long-term heart valve prostheses, whereas contrastingly another system may utilize a polymer which absorbs in 15 minutes and which is useful in implanting anastomotic devices.
Accordingly, it is a primary object of the present invention to provide an endoprosthesis device which is constituted of a combination of superelastic alloys and bioresorbable
5 materials which facilitates the devices to undergo multistage deployments at predetermined intervals while emplaced in the body vessels or lumens of patients.
Another object of the present invention is to provide an endoprosthesis device as described herein, wherein the device may undergo at least two-stage deployment so as to assume different or expanded annular or radial dimensions at predetermined time intervals responsive to degradation of bioresorbable components of the device which have been combined with a superelastic alloy.
A more specific object of the present invention is to provide an endoprosthesis device which is constituted of a heart valve prosthesis for pediatric medical applications, wherein the annulus of the valve prosthesis can be constructed so as to expand in at least two stages of deployment over periods of time during the growth of an infant or child, and wherein the device is constituted of a novel combination of superelastic alloy-materials and bioresorbable materials preferably selected from polymer systems.
BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWINGS
Reference may now be made to the following detailed description of embodiments of the invention, taken in conjunction with the accompanying drawings; in which:
Figures 1 a - 1 d disclose, generally diagrammically, cross-sectional transverse views in the stages of deployment of a coronary stent constituted of a superelastic alloy
Another object of the present invention is to provide an endoprosthesis device as described herein, wherein the device may undergo at least two-stage deployment so as to assume different or expanded annular or radial dimensions at predetermined time intervals responsive to degradation of bioresorbable components of the device which have been combined with a superelastic alloy.
A more specific object of the present invention is to provide an endoprosthesis device which is constituted of a heart valve prosthesis for pediatric medical applications, wherein the annulus of the valve prosthesis can be constructed so as to expand in at least two stages of deployment over periods of time during the growth of an infant or child, and wherein the device is constituted of a novel combination of superelastic alloy-materials and bioresorbable materials preferably selected from polymer systems.
BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWINGS
Reference may now be made to the following detailed description of embodiments of the invention, taken in conjunction with the accompanying drawings; in which:
Figures 1 a - 1 d disclose, generally diagrammically, cross-sectional transverse views in the stages of deployment of a coronary stent constituted of a superelastic alloy
6 combined with a bioresorabable restraining polymer which addresses itself to counteracting the effects of stenosis due to intimal hyperplasia;
Figures 2a - 2d illustrate; diagrammatically in longitudinal sectional views, various stages as to the manner in which a stent comprised of a superelastic alloy and S bioresorabable material can offset post-deployment residual aneurysmal dilation encountered which may be at the neck of a stmt-graft used for abdominal aortic aneurysms (AAA); and Figures 3a and 3b illustrate, respectively, the two-stage deployment offered by the construction of the endoprosthesis device as a heart valve possessing an expandable annular ring or neck portion, and which is especially adapted for use in long-term pediatric medical applications.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE
INVENTION
Reverting more specifically to Figures 1 a through 1 d of the drawings; Figure 1 a illustrates a transverse cross-sectional view through a coronary artery 10 in the pre-stenting stage; showing the interior buildup of plaque 12 along the artery wall 14.
Figure 1b illustrates the artery 10 shown in a post-stenting stage wherein there is illustrated a stent 16 forming a wall interiorly of the plaque 12 and vessel or coronary artery wall 14; whereby as shown in Figure 1 c there may be encountered in-stent restenosis caused by intimal hyperplasia tending to occlude the artery.
In contrast with the foregoing, Figure 1 d illustrates a stent 20 pursuant to the inventive construction incorporates the combination of a suitable bioresorabable restraining polymer 22 with a superelastic alloy 24 on which it may be coated, such as nitinol (nickel-titanium alloy) or the like which may address the effects of intimal hyperplasia.
In particular, the secondary radially expanded deployment of the stmt 20 as a result of the gradual absorption or degradation of the bioresorbable restraining polymer 22 which allows the superelastic alloy the freedom to expand, provides for an effective lumen or blood flow increase; whereby the body vessel diameter itself may increase only slightly.
The bioresorbable restraining polymers which may be employed in this connection may be PLA-PGA copolymer systems, polytyrosine systems, or other suitable polymer systems which can be modified to afford different absorption rates and degrading stages. It is also possible to use two different bioresorbable polymer systems in combination with each other (and with the superelastic alloy) which afford further secondary and tertiary deployment stages to the implanted device.
Referring to Figures 2a through 2d of the drawings, in Figure 2a there is illustrated a bifurcated blood vessel comprising aortic portion 24 extending between the heart and a pair of iliac branches 26a, 26b showing an abdominal aortic aneurysm 28 prior to stenting. As illustrated in Figure 2b, a suitable abdominal aortic aneurysm (AAA) stent or bifurcated aorto-iliac vascular prosthesis 30 which is constituted of the combination of the superelastic alloy material and bioresorbable polymers system or systems, which may be in the form of a stmt-graft construction possesses suitable anastomosis devices (not shown) adapted to exclude the aneurysm, is deployed in the body vessel or lumen.
As illustrated in Figure 2c of the drawings, in the event that the stent-graft structure does not include the bioresorbable materials, the device fails to exclude the aneurysm as a result of encountered post-deployment dilatation of the proximal neck 30a of the device; whereas contrastingly by utilizing the combined materials, such as the superelastic alloy and bioresorbable polymers of the invention, as shown in Figure 2d of the drawings, the resorption and degradation over time of the polymer material allows the stmt-graft to enter a second stage of an additional expansion, thereby forming a protection against the aneurysm and any potential failure of the implanted stent-graft structure or device.
Reverting to the preferred embodiment of the invention, as illustrated in Figures 3a and 3b of the drawings, this diagrammatically discloses a heart valve prosthetic device 40 which is particularly adapted for pediatric applications with infants, children or adolescents who are still subject to growth in heart and heart valve dimensions over protracted periods of time.
As shown in Figure 3a, the valve prosthesis 40 includes a ring construction or annulus 42 constituted in combination of a superelastic alloy, such as nitinol or the like, and a bioresorbable material 44 coated thereon which is adjusted for the growth of a pediatric patient. As implemented, the system of the material 44 utilizes a bioresorbable restraining polymer in combination with the superelastic alloy material 42, such as a PLA-PGA copolymer system, polytyrosine system, or other suitable polymer system or combinations thereof, which can be suitably modified for different absorption rates, such as by degrading, for example, at time intervals ranging from between about 6 months to 200 months, so as to allow for the second-stage in expansion of the prosthesis. As indicated, combinations of two different polymer systems can be employed to afford secondary and tertiary deployment stages at specified time intervals.
Thus, as shown in Figure 3a of the drawings, the annulus of the device as initially implanted in a child, for example of 2 years in age, may possesses a ring or neck diameter Do constituted of a prosthesis of a nitinol ring 42 coated with the polymer system 44.
The secondary expansion, as shown in Figure 3b, which is permitted by the present system, shows the heart valve prosthesis with a diameter of at least 1.1 Do expanded as a result of the polymer absorption, thereby enabling the valve device to be deployed in the body vessel or heart valve of the pediatric patient for extended periods of time during the growth of the patient, without necessitating further surgery for removal of the initial smaller device and substitution of a larger-sized heart valve device.
This clearly lowers the risk of possible morbidity or complications due to any second surgical procedure which have been required for the installation of a larger valve pursuant to the current state in the medical technology.
From the foregoing, it becomes clearly apparent that the invention, wherein in particular S a pediatric heart valve prosthesis is constituted of the combination of superelastic alloy, such as nitinol or the like, and bioresorbable materials comprising various polymers or polymer systems, counteracts deleterious or natural phenomena which may otherwise compromise the performance and efficacy of a two-stage deployable endoprosthetic device which is merely constituted of a superelastic alloy material without resorbable biological materials forming restraining elements degradable over specified periods of time.
While the invention has been particularly shown and described with respect to preferred embodiments thereof, it will be understood by those skilled in the art that the foregoing and other changes in form and details may be made therein without departing from the spirit and scope of the invention.
Figures 2a - 2d illustrate; diagrammatically in longitudinal sectional views, various stages as to the manner in which a stent comprised of a superelastic alloy and S bioresorabable material can offset post-deployment residual aneurysmal dilation encountered which may be at the neck of a stmt-graft used for abdominal aortic aneurysms (AAA); and Figures 3a and 3b illustrate, respectively, the two-stage deployment offered by the construction of the endoprosthesis device as a heart valve possessing an expandable annular ring or neck portion, and which is especially adapted for use in long-term pediatric medical applications.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS OF THE
INVENTION
Reverting more specifically to Figures 1 a through 1 d of the drawings; Figure 1 a illustrates a transverse cross-sectional view through a coronary artery 10 in the pre-stenting stage; showing the interior buildup of plaque 12 along the artery wall 14.
Figure 1b illustrates the artery 10 shown in a post-stenting stage wherein there is illustrated a stent 16 forming a wall interiorly of the plaque 12 and vessel or coronary artery wall 14; whereby as shown in Figure 1 c there may be encountered in-stent restenosis caused by intimal hyperplasia tending to occlude the artery.
In contrast with the foregoing, Figure 1 d illustrates a stent 20 pursuant to the inventive construction incorporates the combination of a suitable bioresorabable restraining polymer 22 with a superelastic alloy 24 on which it may be coated, such as nitinol (nickel-titanium alloy) or the like which may address the effects of intimal hyperplasia.
In particular, the secondary radially expanded deployment of the stmt 20 as a result of the gradual absorption or degradation of the bioresorbable restraining polymer 22 which allows the superelastic alloy the freedom to expand, provides for an effective lumen or blood flow increase; whereby the body vessel diameter itself may increase only slightly.
The bioresorbable restraining polymers which may be employed in this connection may be PLA-PGA copolymer systems, polytyrosine systems, or other suitable polymer systems which can be modified to afford different absorption rates and degrading stages. It is also possible to use two different bioresorbable polymer systems in combination with each other (and with the superelastic alloy) which afford further secondary and tertiary deployment stages to the implanted device.
Referring to Figures 2a through 2d of the drawings, in Figure 2a there is illustrated a bifurcated blood vessel comprising aortic portion 24 extending between the heart and a pair of iliac branches 26a, 26b showing an abdominal aortic aneurysm 28 prior to stenting. As illustrated in Figure 2b, a suitable abdominal aortic aneurysm (AAA) stent or bifurcated aorto-iliac vascular prosthesis 30 which is constituted of the combination of the superelastic alloy material and bioresorbable polymers system or systems, which may be in the form of a stmt-graft construction possesses suitable anastomosis devices (not shown) adapted to exclude the aneurysm, is deployed in the body vessel or lumen.
As illustrated in Figure 2c of the drawings, in the event that the stent-graft structure does not include the bioresorbable materials, the device fails to exclude the aneurysm as a result of encountered post-deployment dilatation of the proximal neck 30a of the device; whereas contrastingly by utilizing the combined materials, such as the superelastic alloy and bioresorbable polymers of the invention, as shown in Figure 2d of the drawings, the resorption and degradation over time of the polymer material allows the stmt-graft to enter a second stage of an additional expansion, thereby forming a protection against the aneurysm and any potential failure of the implanted stent-graft structure or device.
Reverting to the preferred embodiment of the invention, as illustrated in Figures 3a and 3b of the drawings, this diagrammatically discloses a heart valve prosthetic device 40 which is particularly adapted for pediatric applications with infants, children or adolescents who are still subject to growth in heart and heart valve dimensions over protracted periods of time.
As shown in Figure 3a, the valve prosthesis 40 includes a ring construction or annulus 42 constituted in combination of a superelastic alloy, such as nitinol or the like, and a bioresorbable material 44 coated thereon which is adjusted for the growth of a pediatric patient. As implemented, the system of the material 44 utilizes a bioresorbable restraining polymer in combination with the superelastic alloy material 42, such as a PLA-PGA copolymer system, polytyrosine system, or other suitable polymer system or combinations thereof, which can be suitably modified for different absorption rates, such as by degrading, for example, at time intervals ranging from between about 6 months to 200 months, so as to allow for the second-stage in expansion of the prosthesis. As indicated, combinations of two different polymer systems can be employed to afford secondary and tertiary deployment stages at specified time intervals.
Thus, as shown in Figure 3a of the drawings, the annulus of the device as initially implanted in a child, for example of 2 years in age, may possesses a ring or neck diameter Do constituted of a prosthesis of a nitinol ring 42 coated with the polymer system 44.
The secondary expansion, as shown in Figure 3b, which is permitted by the present system, shows the heart valve prosthesis with a diameter of at least 1.1 Do expanded as a result of the polymer absorption, thereby enabling the valve device to be deployed in the body vessel or heart valve of the pediatric patient for extended periods of time during the growth of the patient, without necessitating further surgery for removal of the initial smaller device and substitution of a larger-sized heart valve device.
This clearly lowers the risk of possible morbidity or complications due to any second surgical procedure which have been required for the installation of a larger valve pursuant to the current state in the medical technology.
From the foregoing, it becomes clearly apparent that the invention, wherein in particular S a pediatric heart valve prosthesis is constituted of the combination of superelastic alloy, such as nitinol or the like, and bioresorbable materials comprising various polymers or polymer systems, counteracts deleterious or natural phenomena which may otherwise compromise the performance and efficacy of a two-stage deployable endoprosthetic device which is merely constituted of a superelastic alloy material without resorbable biological materials forming restraining elements degradable over specified periods of time.
While the invention has been particularly shown and described with respect to preferred embodiments thereof, it will be understood by those skilled in the art that the foregoing and other changes in form and details may be made therein without departing from the spirit and scope of the invention.
Claims (32)
1. A radially expandable endoprosthesis having an at least two-stage deployment capability, said endoprosthesis comprising an annulus which subsequent to deployment in a patient is expandable from a first diameter to at least a second larger diameter within a specified interval of time.
2. A radially expandable endoprosthesis as claimed in Claim 1, wherein said annulus comprises a valve prosthesis.
3. A radially expandable endoprosthesis as claimed in Claim 2, wherein said valve prothesis comprises a heart valve prosthesis including a valve.
4. A radially expandable endoprosthesis as claimed in any one of the preceding claims, wherein said endoprosthesis is constituted of a combination of a superelastic alloy and a bioresorbable material.
5. A radially expandable endoprosthesis as claimed in Claim 4, wherein said superelastic alloy comprises nitinol.
6. A radially expandable endoprosthesis as claimed in Claim 4, wherein said bioresorbable material comprises a coating on said superelastic alloy.
7. A radially expandable endoprosthesis as claimed in Claim 4, wherein said bioresorbable material comprises a restraint means on said superelastic alloy.
8. A radially expandable endoprosthesis as claimed in Claim 4, wherein said bioresorbable material is constituted of a polymer system possessing specified rates of resorption so as to enable said annulus to enter said at least second stage of additional radial expansion.
9. A radially expandable endoprosthesis as claimed in Claim 4, wherein the specified interval of time for a resorption of the resorbable material is selected to be in the range of about 6 months to about 200 months at which said annulus expands to the at least second larger diameter.
10. A radially expandable endoprosthesic as claimed in Claim 9, wherein said at least second larger diameter is at least 1.1 times the size of said first diameter.
11. A radially expandable endoprosthesis as claimed in Claim 4, wherein said endoprosthesic comprises a coronary stent for the counteracting of restenosis.
12. A radially expandable endoprosthesis as claimed in Claim 4, wherein said endoprothesis comprises a stent for the stenting of aortic aneurysms.
13. A radially expandable endoprosthesis as claimed in Claim 4, wherein said bioresorbable material is selected to enable said annulus to undergo secondary and tertiary stages of expansion.
14. A radially expandable endoprosthesis as claimed in Claim 8, wherein said polymer system is selected from the group of materials consisting of PLA-PGA copolymer systems, polytyrosine systems, and combinations of differing polymer systems for controllably varying the resorption rates thereof.
15. A radially expandable endoprosthesis as claimed in Claim 8, wherein, said polymer system contains a therapeutic agent.
16. A radially expandable endoprosthesis as claimed in Claim 15, wherein said therapeutic agent selectively comprises an antibiotic, cytostatic or anticoagulant.
17. A method of deploying a radially expandable endoprosthesis having an at least two-stage deployment capability, said endoprosthesis comprising an annulus which subsequent to deployment in a patient is expandable from a first diameter to at least a second larger diameter within a specified interval of time.
18. A method of deploying a radially expandable endoprosthesis as claimed in Claim 17, wherein said annulus comprises a valve prosthesis.
19. A method of deploying a radially expandable endoprosthesis as claimed in Claim 18, wherein said valve prosthesis comprises a heart valve prosthesis including a valve.
20. A method of deploying a radially expandable endoprosthesis as claimed in any one of the preceding Claims 17 through 19, wherein said endoprosthesis is constituted of a combination of a superelastic alloy and a bioresorbable material.
21. A method of deploying radially expandable endoprosthesis as claimed in Claim 20, wherein said superelastic alloy comprises nitinol.
22. A method of deploying a radially expandable endoprosthesis as claimed in Claim 20, wherein said bioresorbable material comprises a coating on said superelastic alloy.
23. A method of deploying a radially expandable endoprosthesis as claimed in Claim 20, wherein said bioresorbable material comprises a restraint means on said superelastic alloy.
24. A method of deploying a radially expandable endoprosthesis as claimed in Claim 20, wherein said bioresorbable material is constituted of a polymer system possessing specified rates of resorption so as to enable said annulus to enter said at least second stage of additional radial expansion.
25. A method of deploying a radially expandable endoprosthesis as claimed in Claim 20, wherein the specified interval of time for a resorption of the resorbable material is selected to be in the range from about 6 months to about 200 months at which said annulus expands to the at least second larger diameter.
26. A method of deploying a radially expandable endoprosthesic as claimed in Claim 25, wherein said at least second larger diameter is at least 1.1 times the size of said first diameter.
27. A method of deploying a radially expandable endoprosthesis as claimed in Claim 20, wherein said endoprosthesic comprises a coronary stent for the counteracting of restenosis.
28. A method of deploying a radially expandable endoprosthesis as claimed in Claim 20, wherein said endoprothesis comprises a stent for the stenting of aortic aneurysms.
29. A method of deploying a radially expandable endoprosthesis as claimed in Claim 20, wherein said bioresorbable material is selected to enable said annulus to undergo secondary and tertiary stages of expansion.
30. A method of deploying a radially expandable endoprosthesis as claimed in Claim 24, wherein said polymer system is selected from the group of materials consisting of PLA-PGA copolymer systems, polytyrosine systems, and combinations of differing polymer systems for controllably varying the resorption rates thereof.
31. A method of deploying a radially expandable endoprosthesis as claimed in Claim 24, wherein said polymer system contains a therapeutic agent.
32. A method of deploying a radially expandable endoprosthesis as claimed in Claim 31, wherein said therapeutic agent selectively comprises an antibiotic, cytostatic or anticoagulant.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/968,481 US20030065386A1 (en) | 2001-09-28 | 2001-09-28 | Radially expandable endoprosthesis device with two-stage deployment |
| US09/968,481 | 2001-09-28 | ||
| PCT/US2002/030828 WO2003028592A1 (en) | 2001-09-28 | 2002-09-27 | Radially expandable endoprosthesis device with two-stage deployment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2461852A1 true CA2461852A1 (en) | 2003-04-10 |
Family
ID=25514327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002461852A Abandoned CA2461852A1 (en) | 2001-09-28 | 2002-09-27 | Radially expandable endoprosthesis device with two-stage deployment |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20030065386A1 (en) |
| EP (1) | EP1435879A4 (en) |
| JP (1) | JP2005504585A (en) |
| CA (1) | CA2461852A1 (en) |
| WO (1) | WO2003028592A1 (en) |
Families Citing this family (175)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6006134A (en) | 1998-04-30 | 1999-12-21 | Medtronic, Inc. | Method and device for electronically controlling the beating of a heart using venous electrical stimulation of nerve fibers |
| US6254564B1 (en) | 1998-09-10 | 2001-07-03 | Percardia, Inc. | Left ventricular conduit with blood vessel graft |
| US7018406B2 (en) | 1999-11-17 | 2006-03-28 | Corevalve Sa | Prosthetic valve for transluminal delivery |
| US8016877B2 (en) | 1999-11-17 | 2011-09-13 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
| US8579966B2 (en) | 1999-11-17 | 2013-11-12 | Medtronic Corevalve Llc | Prosthetic valve for transluminal delivery |
| US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
| US6692513B2 (en) | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
| US7749245B2 (en) | 2000-01-27 | 2010-07-06 | Medtronic, Inc. | Cardiac valve procedure methods and devices |
| DE10010074B4 (en) | 2000-02-28 | 2005-04-14 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Device for fastening and anchoring heart valve prostheses |
| DE10010073B4 (en) * | 2000-02-28 | 2005-12-22 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Anchoring for implantable heart valve prostheses |
| JP2004506469A (en) | 2000-08-18 | 2004-03-04 | アトリテック， インコーポレイテッド | Expandable implantable device for filtering blood flow from the atrial appendage |
| US8623077B2 (en) | 2001-06-29 | 2014-01-07 | Medtronic, Inc. | Apparatus for replacing a cardiac valve |
| US7544206B2 (en) | 2001-06-29 | 2009-06-09 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
| US8771302B2 (en) | 2001-06-29 | 2014-07-08 | Medtronic, Inc. | Method and apparatus for resecting and replacing an aortic valve |
| FR2826863B1 (en) | 2001-07-04 | 2003-09-26 | Jacques Seguin | ASSEMBLY FOR PLACING A PROSTHETIC VALVE IN A BODY CONDUIT |
| FR2828091B1 (en) | 2001-07-31 | 2003-11-21 | Seguin Jacques | ASSEMBLY ALLOWING THE PLACEMENT OF A PROTHETIC VALVE IN A BODY DUCT |
| FR2828263B1 (en) * | 2001-08-03 | 2007-05-11 | Philipp Bonhoeffer | DEVICE FOR IMPLANTATION OF AN IMPLANT AND METHOD FOR IMPLANTATION OF THE DEVICE |
| US7097659B2 (en) | 2001-09-07 | 2006-08-29 | Medtronic, Inc. | Fixation band for affixing a prosthetic heart valve to tissue |
| US8721713B2 (en) | 2002-04-23 | 2014-05-13 | Medtronic, Inc. | System for implanting a replacement valve |
| US7137184B2 (en) * | 2002-09-20 | 2006-11-21 | Edwards Lifesciences Corporation | Continuous heart valve support frame and method of manufacture |
| US9579194B2 (en) | 2003-10-06 | 2017-02-28 | Medtronic ATS Medical, Inc. | Anchoring structure with concave landing zone |
| US9005273B2 (en) | 2003-12-23 | 2015-04-14 | Sadra Medical, Inc. | Assessing the location and performance of replacement heart valves |
| CN101947146B (en) | 2003-12-23 | 2014-08-06 | 萨德拉医学公司 | Relocatable heart valve |
| US8182528B2 (en) | 2003-12-23 | 2012-05-22 | Sadra Medical, Inc. | Locking heart valve anchor |
| US11278398B2 (en) | 2003-12-23 | 2022-03-22 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
| US20050137687A1 (en) | 2003-12-23 | 2005-06-23 | Sadra Medical | Heart valve anchor and method |
| US8603160B2 (en) | 2003-12-23 | 2013-12-10 | Sadra Medical, Inc. | Method of using a retrievable heart valve anchor with a sheath |
| US7959666B2 (en) | 2003-12-23 | 2011-06-14 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a heart valve |
| US7445631B2 (en) | 2003-12-23 | 2008-11-04 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US8840663B2 (en) | 2003-12-23 | 2014-09-23 | Sadra Medical, Inc. | Repositionable heart valve method |
| US7329279B2 (en) | 2003-12-23 | 2008-02-12 | Sadra Medical, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US9526609B2 (en) | 2003-12-23 | 2016-12-27 | Boston Scientific Scimed, Inc. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US7381219B2 (en) | 2003-12-23 | 2008-06-03 | Sadra Medical, Inc. | Low profile heart valve and delivery system |
| US8579962B2 (en) | 2003-12-23 | 2013-11-12 | Sadra Medical, Inc. | Methods and apparatus for performing valvuloplasty |
| US7780725B2 (en) | 2004-06-16 | 2010-08-24 | Sadra Medical, Inc. | Everting heart valve |
| US20050137694A1 (en) | 2003-12-23 | 2005-06-23 | Haug Ulrich R. | Methods and apparatus for endovascularly replacing a patient's heart valve |
| US8343213B2 (en) | 2003-12-23 | 2013-01-01 | Sadra Medical, Inc. | Leaflet engagement elements and methods for use thereof |
| US8828078B2 (en) | 2003-12-23 | 2014-09-09 | Sadra Medical, Inc. | Methods and apparatus for endovascular heart valve replacement comprising tissue grasping elements |
| US20120041550A1 (en) | 2003-12-23 | 2012-02-16 | Sadra Medical, Inc. | Methods and Apparatus for Endovascular Heart Valve Replacement Comprising Tissue Grasping Elements |
| ITTO20040135A1 (en) | 2004-03-03 | 2004-06-03 | Sorin Biomedica Cardio Spa | CARDIAC VALVE PROSTHESIS |
| US8349001B2 (en) * | 2004-04-07 | 2013-01-08 | Medtronic, Inc. | Pharmacological delivery implement for use with cardiac repair devices |
| US20060025857A1 (en) | 2004-04-23 | 2006-02-02 | Bjarne Bergheim | Implantable prosthetic valve |
| US7462191B2 (en) | 2004-06-30 | 2008-12-09 | Edwards Lifesciences Pvt, Inc. | Device and method for assisting in the implantation of a prosthetic valve |
| US20060052867A1 (en) | 2004-09-07 | 2006-03-09 | Medtronic, Inc | Replacement prosthetic heart valve, system and method of implant |
| CA2583591C (en) | 2004-10-02 | 2018-10-30 | Christoph Hans Huber | Methods and devices for repair or replacement of heart valves or adjacent tissue without the need for full cardiopulmonary support |
| US8562672B2 (en) | 2004-11-19 | 2013-10-22 | Medtronic, Inc. | Apparatus for treatment of cardiac valves and method of its manufacture |
| US7186149B2 (en) | 2004-12-06 | 2007-03-06 | Commscope Solutions Properties, Llc | Communications connector for imparting enhanced crosstalk compensation between conductors |
| DE102005003632A1 (en) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Catheter for the transvascular implantation of heart valve prostheses |
| ITTO20050074A1 (en) | 2005-02-10 | 2006-08-11 | Sorin Biomedica Cardio Srl | CARDIAC VALVE PROSTHESIS |
| US7962208B2 (en) | 2005-04-25 | 2011-06-14 | Cardiac Pacemakers, Inc. | Method and apparatus for pacing during revascularization |
| US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
| US7780723B2 (en) * | 2005-06-13 | 2010-08-24 | Edwards Lifesciences Corporation | Heart valve delivery system |
| AU2006275788B2 (en) | 2005-07-29 | 2012-07-26 | Cvdevices, Llc. | Devices and methods for controlling blood perfusion pressure using a retrograde cannula |
| US8128691B2 (en) * | 2005-09-07 | 2012-03-06 | Medtentia International Ltd. Oy | Device and method for improving the function of a heart valve |
| US7569071B2 (en) | 2005-09-21 | 2009-08-04 | Boston Scientific Scimed, Inc. | Venous valve, system, and method with sinus pocket |
| US20070078510A1 (en) | 2005-09-26 | 2007-04-05 | Ryan Timothy R | Prosthetic cardiac and venous valves |
| US8167932B2 (en) | 2005-10-18 | 2012-05-01 | Edwards Lifesciences Corporation | Heart valve delivery system with valve catheter |
| DE102005051849B4 (en) | 2005-10-28 | 2010-01-21 | JenaValve Technology Inc., Wilmington | Device for implantation and attachment of heart valve prostheses |
| DE102005052628B4 (en) * | 2005-11-04 | 2014-06-05 | Jenavalve Technology Inc. | Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter |
| US20070213813A1 (en) | 2005-12-22 | 2007-09-13 | Symetis Sa | Stent-valves for valve replacement and associated methods and systems for surgery |
| US9078781B2 (en) | 2006-01-11 | 2015-07-14 | Medtronic, Inc. | Sterile cover for compressible stents used in percutaneous device delivery systems |
| CN101415379B (en) | 2006-02-14 | 2012-06-20 | 萨德拉医学公司 | Systems for delivering a medical implant |
| WO2007123658A1 (en) | 2006-03-28 | 2007-11-01 | Medtronic, Inc. | Prosthetic cardiac valve formed from pericardium material and methods of making same |
| US7867283B2 (en) * | 2006-05-30 | 2011-01-11 | Boston Scientific Scimed, Inc. | Anti-obesity diverter structure |
| US8876894B2 (en) | 2006-09-19 | 2014-11-04 | Medtronic Ventor Technologies Ltd. | Leaflet-sensitive valve fixation member |
| US11304800B2 (en) | 2006-09-19 | 2022-04-19 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
| US8834564B2 (en) | 2006-09-19 | 2014-09-16 | Medtronic, Inc. | Sinus-engaging valve fixation member |
| WO2008047354A2 (en) | 2006-10-16 | 2008-04-24 | Ventor Technologies Ltd. | Transapical delivery system with ventriculo-arterial overflow bypass |
| JP5593545B2 (en) | 2006-12-06 | 2014-09-24 | メドトロニック シーブイ ルクセンブルク エス．アー．エール．エル． | System and method for transapical delivery of a self-expanding valve secured to an annulus |
| WO2008103280A2 (en) | 2007-02-16 | 2008-08-28 | Medtronic, Inc. | Delivery systems and methods of implantation for replacement prosthetic heart valves |
| US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
| US9138315B2 (en) | 2007-04-13 | 2015-09-22 | Jenavalve Technology Gmbh | Medical device for treating a heart valve insufficiency or stenosis |
| FR2915087B1 (en) | 2007-04-20 | 2021-11-26 | Corevalve Inc | IMPLANT FOR TREATMENT OF A HEART VALVE, IN PARTICULAR OF A MITRAL VALVE, EQUIPMENT INCLUDING THIS IMPLANT AND MATERIAL FOR PLACING THIS IMPLANT. |
| AU2008250552B2 (en) * | 2007-05-15 | 2012-03-08 | Jenavalve Technology Inc. | Handle for manipulating a catheter tip, catheter system and medical insertion system for inserting a self-expandable heart valve stent |
| US8747458B2 (en) | 2007-08-20 | 2014-06-10 | Medtronic Ventor Technologies Ltd. | Stent loading tool and method for use thereof |
| US10856970B2 (en) | 2007-10-10 | 2020-12-08 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve for transfemoral delivery |
| US9848981B2 (en) | 2007-10-12 | 2017-12-26 | Mayo Foundation For Medical Education And Research | Expandable valve prosthesis with sealing mechanism |
| US9149358B2 (en) | 2008-01-24 | 2015-10-06 | Medtronic, Inc. | Delivery systems for prosthetic heart valves |
| US8628566B2 (en) | 2008-01-24 | 2014-01-14 | Medtronic, Inc. | Stents for prosthetic heart valves |
| US7972378B2 (en) | 2008-01-24 | 2011-07-05 | Medtronic, Inc. | Stents for prosthetic heart valves |
| US8157852B2 (en) | 2008-01-24 | 2012-04-17 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
| US9393115B2 (en) | 2008-01-24 | 2016-07-19 | Medtronic, Inc. | Delivery systems and methods of implantation for prosthetic heart valves |
| EP2254512B1 (en) | 2008-01-24 | 2016-01-06 | Medtronic, Inc. | Markers for prosthetic heart valves |
| US8398704B2 (en) | 2008-02-26 | 2013-03-19 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
| US8465540B2 (en) | 2008-02-26 | 2013-06-18 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis |
| US8317858B2 (en) * | 2008-02-26 | 2012-11-27 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
| US9168130B2 (en) | 2008-02-26 | 2015-10-27 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
| US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
| WO2011104269A1 (en) | 2008-02-26 | 2011-09-01 | Jenavalve Technology Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
| EP3915525A1 (en) | 2008-02-28 | 2021-12-01 | Medtronic, Inc. | Prosthetic heart valve systems |
| US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
| US8430927B2 (en) | 2008-04-08 | 2013-04-30 | Medtronic, Inc. | Multiple orifice implantable heart valve and methods of implantation |
| US8696743B2 (en) | 2008-04-23 | 2014-04-15 | Medtronic, Inc. | Tissue attachment devices and methods for prosthetic heart valves |
| US8312825B2 (en) | 2008-04-23 | 2012-11-20 | Medtronic, Inc. | Methods and apparatuses for assembly of a pericardial prosthetic heart valve |
| US8840661B2 (en) | 2008-05-16 | 2014-09-23 | Sorin Group Italia S.R.L. | Atraumatic prosthetic heart valve prosthesis |
| EP2520320B1 (en) | 2008-07-01 | 2016-11-02 | Endologix, Inc. | Catheter system |
| WO2010031060A1 (en) | 2008-09-15 | 2010-03-18 | Medtronic Ventor Technologies Ltd. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
| US8721714B2 (en) | 2008-09-17 | 2014-05-13 | Medtronic Corevalve Llc | Delivery system for deployment of medical devices |
| JP5607639B2 (en) | 2008-10-10 | 2014-10-15 | サドラ メディカル インコーポレイテッド | Medical devices and systems |
| US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
| US8986361B2 (en) | 2008-10-17 | 2015-03-24 | Medtronic Corevalve, Inc. | Delivery system for deployment of medical devices |
| ES2551694T3 (en) | 2008-12-23 | 2015-11-23 | Sorin Group Italia S.R.L. | Expandable prosthetic valve with anchoring appendages |
| EP2628465A1 (en) | 2009-04-27 | 2013-08-21 | Sorin Group Italia S.r.l. | Prosthetic vascular conduit |
| US20100292779A1 (en) * | 2009-05-15 | 2010-11-18 | Helmut Straubinger | Device for compressing a stent and a system as well as a method for loading a stent into a medical delivery system |
| EP3434225B1 (en) | 2009-06-23 | 2023-11-01 | Endospan Ltd. | Vascular prosthesis for treating aneurysms |
| WO2011004374A1 (en) | 2009-07-09 | 2011-01-13 | Endospan Ltd. | Apparatus for closure of a lumen and methods of using the same |
| US8808369B2 (en) | 2009-10-05 | 2014-08-19 | Mayo Foundation For Medical Education And Research | Minimally invasive aortic valve replacement |
| US9226826B2 (en) | 2010-02-24 | 2016-01-05 | Medtronic, Inc. | Transcatheter valve structure and methods for valve delivery |
| US8652204B2 (en) | 2010-04-01 | 2014-02-18 | Medtronic, Inc. | Transcatheter valve with torsion spring fixation and related systems and methods |
| US11278406B2 (en) | 2010-05-20 | 2022-03-22 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient, insertion system with a catheter system and medical device for treatment of a heart valve defect |
| US10856978B2 (en) | 2010-05-20 | 2020-12-08 | Jenavalve Technology, Inc. | Catheter system |
| IT1400327B1 (en) | 2010-05-21 | 2013-05-24 | Sorin Biomedica Cardio Srl | SUPPORT DEVICE FOR VALVULAR PROSTHESIS AND CORRESPONDING CORRESPONDENT. |
| CN103002833B (en) | 2010-05-25 | 2016-05-11 | 耶拿阀门科技公司 | Artificial heart valve and comprise artificial heart valve and support through conduit carry interior prosthese |
| EP2611388B1 (en) | 2010-09-01 | 2022-04-27 | Medtronic Vascular Galway | Prosthetic valve support structure |
| CA2808673C (en) | 2010-09-10 | 2019-07-02 | Symetis Sa | Valve replacement devices, delivery device for a valve replacement device and method of production of a valve replacement device |
| US9579193B2 (en) | 2010-09-23 | 2017-02-28 | Transmural Systems Llc | Methods and systems for delivering prostheses using rail techniques |
| WO2012061809A2 (en) * | 2010-11-06 | 2012-05-10 | Mehr Medical Llc | Methods and systems for delivering prostheses using rail techniques |
| US10321998B2 (en) | 2010-09-23 | 2019-06-18 | Transmural Systems Llc | Methods and systems for delivering prostheses using rail techniques |
| EP2486894B1 (en) | 2011-02-14 | 2021-06-09 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
| EP2486893B1 (en) | 2011-02-14 | 2017-07-05 | Sorin Group Italia S.r.l. | Sutureless anchoring device for cardiac valve prostheses |
| EP2680915B1 (en) | 2011-03-01 | 2021-12-22 | Endologix LLC | Catheter system |
| EP2520251A1 (en) | 2011-05-05 | 2012-11-07 | Symetis SA | Method and Apparatus for Compressing Stent-Valves |
| WO2013009975A1 (en) | 2011-07-12 | 2013-01-17 | Boston Scientific Scimed, Inc. | Coupling system for medical devices |
| WO2013030818A2 (en) | 2011-08-28 | 2013-03-07 | Endospan Ltd. | Stent-grafts with post-deployment variable axial and radial displacement |
| US9549817B2 (en) | 2011-09-22 | 2017-01-24 | Transmural Systems Llc | Devices, systems and methods for repairing lumenal systems |
| US9510947B2 (en) | 2011-10-21 | 2016-12-06 | Jenavalve Technology, Inc. | Catheter system for introducing an expandable heart valve stent into the body of a patient |
| US9427339B2 (en) | 2011-10-30 | 2016-08-30 | Endospan Ltd. | Triple-collar stent-graft |
| US8951243B2 (en) | 2011-12-03 | 2015-02-10 | Boston Scientific Scimed, Inc. | Medical device handle |
| WO2013084235A2 (en) | 2011-12-04 | 2013-06-13 | Endospan Ltd. | Branched stent-graft system |
| EP2842517A1 (en) | 2011-12-29 | 2015-03-04 | Sorin Group Italia S.r.l. | A kit for implanting prosthetic vascular conduits |
| US10172708B2 (en) | 2012-01-25 | 2019-01-08 | Boston Scientific Scimed, Inc. | Valve assembly with a bioabsorbable gasket and a replaceable valve implant |
| US9770350B2 (en) | 2012-05-15 | 2017-09-26 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
| DE202013011734U1 (en) | 2012-05-16 | 2014-04-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | A catheter delivery system for inserting an expandable heart valve prosthesis and a medical device for treating a valvular defect |
| US9883941B2 (en) | 2012-06-19 | 2018-02-06 | Boston Scientific Scimed, Inc. | Replacement heart valve |
| EP2991586A1 (en) | 2013-05-03 | 2016-03-09 | Medtronic Inc. | Valve delivery tool |
| JP6563394B2 (en) | 2013-08-30 | 2019-08-21 | イェーナヴァルヴ テクノロジー インコーポレイテッド | Radially foldable frame for an artificial valve and method for manufacturing the frame |
| EP2853237A1 (en) | 2013-09-25 | 2015-04-01 | Universität Zürich | Biological heart valve replacement, particularly for pediatric patients, and manufacturing method |
| US10603197B2 (en) | 2013-11-19 | 2020-03-31 | Endospan Ltd. | Stent system with radial-expansion locking |
| US20170014115A1 (en) | 2014-03-27 | 2017-01-19 | Transmural Systems Llc | Devices and methods for closure of transvascular or transcameral access ports |
| US9901445B2 (en) | 2014-11-21 | 2018-02-27 | Boston Scientific Scimed, Inc. | Valve locking mechanism |
| CA2967904C (en) | 2014-12-18 | 2023-01-10 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
| WO2016115375A1 (en) | 2015-01-16 | 2016-07-21 | Boston Scientific Scimed, Inc. | Displacement based lock and release mechanism |
| US9861477B2 (en) | 2015-01-26 | 2018-01-09 | Boston Scientific Scimed Inc. | Prosthetic heart valve square leaflet-leaflet stitch |
| US9788942B2 (en) | 2015-02-03 | 2017-10-17 | Boston Scientific Scimed Inc. | Prosthetic heart valve having tubular seal |
| WO2016126524A1 (en) | 2015-02-03 | 2016-08-11 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having tubular seal |
| US10285809B2 (en) | 2015-03-06 | 2019-05-14 | Boston Scientific Scimed Inc. | TAVI anchoring assist device |
| US10426617B2 (en) | 2015-03-06 | 2019-10-01 | Boston Scientific Scimed, Inc. | Low profile valve locking mechanism and commissure assembly |
| US10080652B2 (en) | 2015-03-13 | 2018-09-25 | Boston Scientific Scimed, Inc. | Prosthetic heart valve having an improved tubular seal |
| CN107530168B (en) | 2015-05-01 | 2020-06-09 | 耶拿阀门科技股份有限公司 | Device and method with reduced pacemaker ratio in heart valve replacement |
| CN107624056B (en) | 2015-06-30 | 2020-06-09 | 恩朵罗杰克斯股份有限公司 | Locking assembly and related system and method |
| US10195392B2 (en) | 2015-07-02 | 2019-02-05 | Boston Scientific Scimed, Inc. | Clip-on catheter |
| WO2017004377A1 (en) | 2015-07-02 | 2017-01-05 | Boston Scientific Scimed, Inc. | Adjustable nosecone |
| US10136991B2 (en) | 2015-08-12 | 2018-11-27 | Boston Scientific Scimed Inc. | Replacement heart valve implant |
| US10179041B2 (en) | 2015-08-12 | 2019-01-15 | Boston Scientific Scimed Icn. | Pinless release mechanism |
| EP3349687B1 (en) | 2015-09-15 | 2020-09-09 | THE UNITED STATES OF AMERICA, represented by the S | Devices for effectuating percutaneous glenn and fontan procedures |
| US10342660B2 (en) | 2016-02-02 | 2019-07-09 | Boston Scientific Inc. | Tensioned sheathing aids |
| US10583005B2 (en) | 2016-05-13 | 2020-03-10 | Boston Scientific Scimed, Inc. | Medical device handle |
| EP4183371A1 (en) | 2016-05-13 | 2023-05-24 | JenaValve Technology, Inc. | Heart valve prosthesis delivery system and method for delivery of heart valve prosthesis with introducer sheath and loading system |
| US10201416B2 (en) | 2016-05-16 | 2019-02-12 | Boston Scientific Scimed, Inc. | Replacement heart valve implant with invertible leaflets |
| JP7094965B2 (en) | 2017-01-27 | 2022-07-04 | イエナバルブ テクノロジー インク | Heart valve imitation |
| WO2018226915A1 (en) | 2017-06-08 | 2018-12-13 | Boston Scientific Scimed, Inc. | Heart valve implant commissure support structure |
| CN111163729B (en) | 2017-08-01 | 2022-03-29 | 波士顿科学国际有限公司 | Medical implant locking mechanism |
| US10939996B2 (en) | 2017-08-16 | 2021-03-09 | Boston Scientific Scimed, Inc. | Replacement heart valve commissure assembly |
| US11076954B2 (en) | 2017-09-21 | 2021-08-03 | The Cleveland Clinic Foundation | Gradually-expandable stent apparatus and method |
| US11246625B2 (en) | 2018-01-19 | 2022-02-15 | Boston Scientific Scimed, Inc. | Medical device delivery system with feedback loop |
| JP7055882B2 (en) | 2018-01-19 | 2022-04-18 | ボストン サイエンティフィック サイムド，インコーポレイテッド | Guidance mode indwelling sensor for transcatheter valve system |
| US11147668B2 (en) | 2018-02-07 | 2021-10-19 | Boston Scientific Scimed, Inc. | Medical device delivery system with alignment feature |
| WO2019165394A1 (en) | 2018-02-26 | 2019-08-29 | Boston Scientific Scimed, Inc. | Embedded radiopaque marker in adaptive seal |
| CN112399836A (en) | 2018-05-15 | 2021-02-23 | 波士顿科学国际有限公司 | Replacement heart valve commissure assemblies |
| WO2019224577A1 (en) | 2018-05-23 | 2019-11-28 | Sorin Group Italia S.R.L. | A cardiac valve prosthesis |
| US11241310B2 (en) | 2018-06-13 | 2022-02-08 | Boston Scientific Scimed, Inc. | Replacement heart valve delivery device |
| WO2020123486A1 (en) | 2018-12-10 | 2020-06-18 | Boston Scientific Scimed, Inc. | Medical device delivery system including a resistance member |
| US10702407B1 (en) | 2019-02-28 | 2020-07-07 | Renata Medical, Inc. | Growth stent for congenital narrowings |
| US11439504B2 (en) | 2019-05-10 | 2022-09-13 | Boston Scientific Scimed, Inc. | Replacement heart valve with improved cusp washout and reduced loading |
| US11937823B2 (en) | 2019-07-09 | 2024-03-26 | Venacore Inc. | Gradually restricting vascular blood flow |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657744A (en) * | 1970-05-08 | 1972-04-25 | Univ Minnesota | Method for fixing prosthetic implants in a living body |
| US3839741A (en) * | 1972-11-17 | 1974-10-08 | J Haller | Heart valve and retaining means therefor |
| DE3230858C2 (en) * | 1982-08-19 | 1985-01-24 | Ahmadi, Ali, Dr. med., 7809 Denzlingen | Ring prosthesis |
| US5411552A (en) * | 1990-05-18 | 1995-05-02 | Andersen; Henning R. | Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis |
| DK124690D0 (en) * | 1990-05-18 | 1990-05-18 | Henning Rud Andersen | FAT PROTECTION FOR IMPLEMENTATION IN THE BODY FOR REPLACEMENT OF NATURAL FLEET AND CATS FOR USE IN IMPLEMENTING A SUCH FAT PROTECTION |
| SK41493A3 (en) * | 1990-10-29 | 1993-08-11 | Procter & Gamble | Sanitary napkin having components capable of separation in use |
| US5234457A (en) * | 1991-10-09 | 1993-08-10 | Boston Scientific Corporation | Impregnated stent |
| US5383926A (en) * | 1992-11-23 | 1995-01-24 | Children's Medical Center Corporation | Re-expandable endoprosthesis |
| US5441515A (en) * | 1993-04-23 | 1995-08-15 | Advanced Cardiovascular Systems, Inc. | Ratcheting stent |
| US5824044A (en) * | 1994-05-12 | 1998-10-20 | Endovascular Technologies, Inc. | Bifurcated multicapsule intraluminal grafting system |
| US6217610B1 (en) * | 1994-07-29 | 2001-04-17 | Edwards Lifesciences Corporation | Expandable annuloplasty ring |
| AU719980B2 (en) * | 1995-02-22 | 2000-05-18 | Menlo Care, Inc. | Covered expanding mesh stent |
| US6818014B2 (en) * | 1995-03-01 | 2004-11-16 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
| US5843158A (en) * | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
| EP0955954B1 (en) * | 1996-01-05 | 2005-03-16 | Medtronic, Inc. | Expansible endoluminal prostheses |
| DE19624948A1 (en) * | 1996-06-24 | 1998-01-02 | Adiam Medizintechnik Gmbh & Co | Prosthetic heart valve |
| US5830217A (en) * | 1996-08-09 | 1998-11-03 | Thomas J. Fogarty | Soluble fixation device and method for stent delivery catheters |
| US6086610A (en) * | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
| US6152956A (en) * | 1997-01-28 | 2000-11-28 | Pierce; George E. | Prosthesis for endovascular repair of abdominal aortic aneurysms |
| US5855597A (en) * | 1997-05-07 | 1999-01-05 | Iowa-India Investments Co. Limited | Stent valve and stent graft for percutaneous surgery |
| US5972029A (en) * | 1997-05-13 | 1999-10-26 | Fuisz Technologies Ltd. | Remotely operable stent |
| US5899935A (en) * | 1997-08-04 | 1999-05-04 | Schneider (Usa) Inc. | Balloon expandable braided stent with restraint |
| US5957975A (en) * | 1997-12-15 | 1999-09-28 | The Cleveland Clinic Foundation | Stent having a programmed pattern of in vivo degradation |
| US6336937B1 (en) * | 1998-12-09 | 2002-01-08 | Gore Enterprise Holdings, Inc. | Multi-stage expandable stent-graft |
| US6350277B1 (en) * | 1999-01-15 | 2002-02-26 | Scimed Life Systems, Inc. | Stents with temporary retaining bands |
| US6458153B1 (en) * | 1999-12-31 | 2002-10-01 | Abps Venture One, Ltd. | Endoluminal cardiac and venous valve prostheses and methods of manufacture and delivery thereof |
| US6406493B1 (en) * | 2000-06-02 | 2002-06-18 | Hosheng Tu | Expandable annuloplasty ring and methods of use |
| US7510572B2 (en) * | 2000-09-12 | 2009-03-31 | Shlomo Gabbay | Implantation system for delivery of a heart valve prosthesis |
| US20020103526A1 (en) * | 2000-12-15 | 2002-08-01 | Tom Steinke | Protective coating for stent |
| US6613077B2 (en) * | 2001-03-27 | 2003-09-02 | Scimed Life Systems, Inc. | Stent with controlled expansion |
-
2001
- 2001-09-28 US US09/968,481 patent/US20030065386A1/en not_active Abandoned
-
2002
- 2002-09-27 WO PCT/US2002/030828 patent/WO2003028592A1/en active Application Filing
- 2002-09-27 CA CA002461852A patent/CA2461852A1/en not_active Abandoned
- 2002-09-27 EP EP02773630A patent/EP1435879A4/en not_active Withdrawn
- 2002-09-27 JP JP2003531932A patent/JP2005504585A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP1435879A4 (en) | 2006-08-23 |
| US20030065386A1 (en) | 2003-04-03 |
| JP2005504585A (en) | 2005-02-17 |
| EP1435879A1 (en) | 2004-07-14 |
| WO2003028592A1 (en) | 2003-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20030065386A1 (en) | Radially expandable endoprosthesis device with two-stage deployment | |
| EP1933761B1 (en) | Inflatable bifurcation stent | |
| US5578075A (en) | Minimally invasive bioactivated endoprosthesis for vessel repair | |
| US5449382A (en) | Minimally invasive bioactivated endoprosthesis for vessel repair | |
| EP1372530B1 (en) | Stent with controlled expansion | |
| US7637940B2 (en) | Stent with bioabsorbable membrane | |
| US6969401B1 (en) | Endovascular prosthesis | |
| US8002816B2 (en) | Prosthesis for implantation in aorta and method of using same | |
| JP5458324B2 (en) | Thin medical device | |
| US20020165601A1 (en) | Bioabsorbable stent-graft and covered stent | |
| US20020133221A1 (en) | Expandable intraluminal graft | |
| US20050222671A1 (en) | Partially biodegradable stent | |
| US20030045923A1 (en) | Hybrid balloon expandable/self expanding stent | |
| JPH10328216A (en) | Stent for treating bifurcate vessel and stent graft | |
| WO2009120458A2 (en) | Stent prosthesis having select flared crowns | |
| JP2008541840A (en) | Selective treatment of side branch petals of stent | |
| CA2618215A1 (en) | Stent with expanding side branch geometry | |
| US7556643B2 (en) | Graft inside stent | |
| JP2007508900A (en) | Natural tissue stent | |
| CN110868960B (en) | Endovascular prosthesis | |
| US20090259299A1 (en) | Side Branch Stent Having a Proximal Flexible Material Section | |
| AU2002228982A1 (en) | Stent with controlled expansion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Dead |